Published in J Cell Sci on November 01, 1994
Identification of Plasmodium falciparum erythrocyte membrane protein 1 (PfEMP1) as the rosetting ligand of the malaria parasite P. falciparum. J Exp Med (1998) 2.83
Binding of syndecan-like cell surface proteoglycan receptors is required for Neisseria gonorrhoeae entry into human mucosal cells. EMBO J (1995) 2.37
A splice variant of CD44 expressed in the apical ectodermal ridge presents fibroblast growth factors to limb mesenchyme and is required for limb outgrowth. Genes Dev (1998) 1.73
Syndecan-1 and E-cadherin expression in differentiated type of early gastric cancer. World J Gastroenterol (2005) 1.45
Essential roles for soluble virion-associated heparan sulfonated proteoglycans and growth factors in human papillomavirus infections. PLoS Pathog (2012) 1.36
Protein kinase C regulates the recruitment of syndecan-4 into focal contacts. Mol Biol Cell (1995) 1.18
Cellular signaling by fibroblast growth factors (FGFs) and their receptors (FGFRs) in male reproduction. Endocr Rev (2008) 1.10
Selective activation of TACI by syndecan-2. Blood (2005) 1.09
Proteoglycan signaling co-receptors: roles in cell adhesion, migration and invasion. Cell Signal (2009) 1.04
Detection and characterization of plasma cells in peripheral blood: correlation of IgE+ plasma cell frequency with IgE serum titre. Clin Exp Immunol (2002) 1.01
Syndecan-1 and FGF-2, but not FGF receptor-1, share a common transport route and co-localize with heparanase in the nuclei of mesenchymal tumor cells. PLoS One (2009) 0.97
Ligand binding to heparan sulfate proteoglycans induces their aggregation and distribution along actin cytoskeleton. Mol Biol Cell (1996) 0.97
NG2 proteoglycan and the actin-binding protein fascin define separate populations of actin-containing filopodia and lamellipodia during cell spreading and migration. Mol Biol Cell (1996) 0.91
Syndecans in cartilage breakdown and synovial inflammation. Nat Rev Rheumatol (2012) 0.90
Human endothelial cell interaction with biomimetic surfactant polymers containing Peptide ligands from the heparin binding domain of fibronectin. Tissue Eng (2005) 0.86
Circulating sCD138 and some angiogenesis-involved cytokines help to anticipate the disease progression of early-stage B-cell chronic lymphocytic leukemia. Mediators Inflamm (2006) 0.85
Novel genes and pathways modulated by syndecan-1: implications for the proliferation and cell-cycle regulation of malignant mesothelioma cells. PLoS One (2012) 0.85
Syndecan-4: dispensable or indispensable? Glycoconj J (2003) 0.85
Strategies to enhance transductional efficiency of adenoviral-based gene transfer to primary human fibroblasts and keratinocytes as a platform in dermal wounds. Wound Repair Regen (2006) 0.80
Interaction of human papillomavirus type 16 particles with heparan sulfate and syndecan-1 molecules in the keratinocyte extracellular matrix plays an active role in infection. J Gen Virol (2015) 0.78
The hierarchical process of differentiation of long-lived antibody-secreting cells is dependent on integrated signals derived from antigen and IL-17A. PLoS One (2013) 0.77
Bone marrow plasma cell assessment before peripheral blood stem cell mobilization in patients with multiple myeloma undergoing autologous stem cell transplantation. Biomed Res Int (2014) 0.76
Immunohistochemical analysis of syndecan-1 in leukoplakia and oral submucous fibrosis. Dent Res J (Isfahan) (2013) 0.75
Molecular cloning of syndecan, an integral membrane proteoglycan. J Cell Biol (1989) 2.88
Lymphocyte CD44 binds the COOH-terminal heparin-binding domain of fibronectin. J Cell Biol (1992) 2.52
Biochemical properties of glycoproteins involved in lymphocyte recognition of high endothelial venules in man. J Immunol (1988) 2.39
Cell surface proteoglycan associates with the cytoskeleton at the basolateral cell surface of mouse mammary epithelial cells. J Cell Biol (1986) 2.16
Immunocytochemistry of cell surface heparan sulfate proteoglycan in mouse tissues. A light and electron microscopic study. J Histochem Cytochem (1987) 2.07
Psychological performance of subjects with low exposure to lead. J Occup Med (1978) 2.05
Heparan sulfate proteoglycans from mouse mammary epithelial cells: localization on the cell surface with a monoclonal antibody. J Cell Biol (1985) 1.88
The cell surface proteoglycan from mouse mammary epithelial cells bears chondroitin sulfate and heparan sulfate glycosaminoglycans. J Biol Chem (1985) 1.71
Induced expression of syndecan in healing wounds. J Cell Biol (1991) 1.67
Enhanced expression of the tie receptor tyrosine kinase in endothelial cells during neovascularization. Blood (1992) 1.65
Sequence of human syndecan indicates a novel gene family of integral membrane proteoglycans. J Biol Chem (1990) 1.60
Expression of proteoglycans and hyaluronan during wound healing. J Histochem Cytochem (1995) 1.42
Syndecan from embryonic tooth mesenchyme binds tenascin. J Biol Chem (1991) 1.37
Expression of the heparin-binding cytokines, midkine (MK) and HB-GAM (pleiotrophin) is associated with epithelial-mesenchymal interactions during fetal development and organogenesis. Development (1995) 1.30
Syndecan expression regulates cell morphology and growth of mouse mammary epithelial tumor cells. Proc Natl Acad Sci U S A (1992) 1.29
Cell surface proteoglycan expression correlates with epithelial-mesenchymal interaction during tooth morphogenesis. Dev Biol (1988) 1.28
Epithelial-mesenchymal interactions regulate the stage-specific expression of a cell surface proteoglycan, syndecan, in the developing kidney. Dev Biol (1989) 1.23
Syndecan and tenascin expression is induced by epithelial-mesenchymal interactions in embryonic tooth mesenchyme. J Cell Biol (1989) 1.19
Binding of human syndecan to extracellular matrix proteins. J Biol Chem (1990) 1.17
Biosynthesis of heparin/heparan sulfate. cDNA cloning and expression of D-glucuronyl C5-epimerase from bovine lung. J Biol Chem (1997) 1.16
Neurite growth-promoting protein (amphoterin, p30) binds syndecan. Exp Cell Res (1992) 1.13
Association between syndecan-1 expression and clinical outcome in squamous cell carcinoma of the head and neck. Br J Cancer (1994) 1.12
Characterization of the D-glucuronyl C5-epimerase involved in the biosynthesis of heparin and heparan sulfate. J Biol Chem (2001) 1.10
Growth factors induce 3T3 cells to express bFGF-binding syndecan. J Biol Chem (1992) 1.07
Syndecan-1 expression has prognostic significance in head and neck carcinoma. Br J Cancer (1999) 1.03
Transient expression of syndecan in mesenchymal cell aggregates of the embryonic kidney. Dev Biol (1992) 1.02
Analysis of transport and targeting of syndecan-1: effect of cytoplasmic tail deletions. Mol Biol Cell (1994) 1.01
Suppression of tumor cell growth by syndecan-1 ectodomain. J Biol Chem (1994) 0.99
Syndecan-1: a new prognostic marker in laryngeal cancer. Acta Otolaryngol (1997) 0.98
Steroid-induced epithelial-fibroblastic conversion associated with syndecan suppression in S115 mouse mammary tumor cells. Cell Regul (1991) 0.98
Expression of syndecan gene is induced early, is transient, and correlates with changes in mesenchymal cell proliferation during tooth organogenesis. Dev Biol (1991) 0.98
Syndecan-1 expression in mammary epithelial tumor cells is E-cadherin-dependent. J Cell Sci (1996) 0.96
Immunohistochemical localization of syndecan-1 in normal and pathological human uterine cervix. J Pathol (1994) 0.95
The role of syndecan-1 in malignancies. Ann Med (1996) 0.95
Expression of integrin family of cell adhesion receptors in rheumatoid synovium. Alpha 6 integrin subunit in normal and hyperplastic synovial lining cell layer. Am J Pathol (1993) 0.94
Immunological detection of proteins after isoelectric focusing in thin layer agarose gel: a specific application for the characterization of immunoglobulin diversity. J Clin Lab Immunol (1983) 0.94
Expression of syndecan-1 is induced by differentiation and suppressed by malignant transformation of human keratinocytes. Eur J Cell Biol (1994) 0.93
Improved application of the diphenylamine reaction for the determination of DNA. J Biochem Biophys Methods (1980) 0.93
High syndecan-1 expression is associated with favourable outcome in squamous cell lung carcinoma treated with radical surgery. Lung Cancer (2001) 0.92
Inhibition of basic fibroblast growth factor-induced growth promotion by overexpression of syndecan-1. J Biol Chem (1993) 0.91
Binding of heparin/heparan sulfate to fibroblast growth factor receptor 4. J Biol Chem (2001) 0.91
Immunohistochemical localization of syndecan in mouse skin tumors induced by UV irradiation. Loss of expression associated with malignant transformation. Am J Pathol (1991) 0.91
Use of a hollow fiber bioreactor for large-scale production of alpha 2-adrenoceptors in mammalian cells. J Biotechnol (1994) 0.91
Basic fibroblast growth factor-syndecan complex at cell surface or immobilized to matrix promotes cell growth. J Biol Chem (1992) 0.90
Syndecan family of cell surface proteoglycans: developmentally regulated receptors for extracellular effector molecules. Experientia (1995) 0.89
Defect in the generation of light-chain diversity in bursectomized chickens. Nature (1984) 0.89
Increased glycosylation of beta 1 integrins affects the interaction of transformed S115 mammary epithelial cells with laminin-1. Cell Growth Differ (1995) 0.89
Effect of silica on a culture of rat peritoneal macrophages. Ann Occup Hyg (1979) 0.88
Suppression of syndecan-1 expression in endothelial cells by tumor necrosis factor-alpha. J Biol Chem (1996) 0.88
Monoclonal antibodies to Bacteroides fragilis lipopolysaccharide. J Clin Microbiol (1984) 0.88
Enhanced synthesis of hyaluronic acid by human gingival fibroblasts exposed to human dental bacterial extract. J Periodontal Res (1983) 0.87
Activation of an enhancer on the syndecan-1 gene is restricted to fibroblast growth factor family members in mesenchymal cells. Mol Cell Biol (1997) 0.87
The cytoplasmic domain of syndecan-1 is not required for association with Triton X-100-insoluble material. J Cell Sci (1994) 0.87
Expression of Mad, an antagonist of Myc oncoprotein function, in differentiating keratinocytes during tumorigenesis of the skin. Br J Cancer (1996) 0.87
Syndecan in carcinomas produced from transformed epithelial cells in nude mice. Lab Invest (1992) 0.86
Wound reepithelialization activates a growth factor-responsive enhancer in migrating keratinocytes. FASEB J (1998) 0.86
Connective tissue activating macromolecules in macrophage culture medium. Connect Tissue Res (1981) 0.85
Characterization of the perivascular reticulin network in a case of primary brain lymphoma. Immunohistochemical demonstration of collagen types I, III, IV, and V; laminin; and fibronectin. Acta Neuropathol (1985) 0.85
Involvement of protein kinase A in fibroblast growth factor-2-activated transcription. Proc Natl Acad Sci U S A (2000) 0.84
Expression of small extracellular chondroitin/dermatan sulfate proteoglycans is differentially regulated in human endothelial cells. J Biol Chem (1997) 0.84
Association of syndecan-1 with tumor grade and histology in primary invasive cervical carcinoma. Gynecol Oncol (1999) 0.84
Functional characterization of mouse syndecan-1 promoter. J Biol Chem (1996) 0.84
Structural organization and genomic sequence of mouse syndecan-1 gene. J Biol Chem (1993) 0.83
Syndecan-1 expression is upregulated in degenerating articular cartilage in a transgenic mouse model for osteoarthritis. Scand J Rheumatol (2006) 0.83
Effect of five anti-inflammatory steroids on collagen and glycoaminoglycan synthessis in vitro. Br J Dermatol (1980) 0.83
Is the sensitivity of cells for FGF-1 and FGF-2 regulated by cell surface heparan sulfate proteoglycans? Eur J Cell Biol (1997) 0.83
Enhanced fibroblast collagen production by a macrophage-derived factor (CEMF). Biochem Biophys Res Commun (1982) 0.82
Cell-matrix interactions in tooth development. Int J Dev Biol (1989) 0.82
A novel laminin-binding form of syndecan-1 (cell surface proteoglycan) produced by syndecan-1 cDNA-transfected NIH-3T3 cells. Exp Cell Res (1994) 0.82
Stable expression of recombinant human alpha 2-adrenoceptor subtypes in two mammalian cell lines: characterization with [3H]rauwolscine binding, inhibition of adenylate cyclase and RNase protection assay. Biochim Biophys Acta (1992) 0.81
Viable AC-2, a new adult bovine serum- and colostrum-based supplement for the culture of mammalian cells. Biotechniques (1996) 0.81
Biology of cell surface heparan sulfate proteoglycans. Med Biol (1987) 0.81
Transcriptional regulation of Syndecan-1 expression by growth factors. Prog Nucleic Acid Res Mol Biol (1999) 0.80
Wound fluids mediate granulation tissue growth phases. Cell Biol Int Rep (1983) 0.79
The activation and composition of FiRE (an FGF-inducible response element) differ in a cell type- and growth factor-specific manner. Oncogene (1998) 0.79
Collagen types and fibronectin in the uterine muscle of normal and hypertensive pregnant patients. Am J Obstet Gynecol (1984) 0.79
Extracellular matrix-dependent activation of syndecan-1 expression in keratinocyte growth factor-treated keratinocytes. J Biol Chem (1999) 0.79
Expression and glycosylation studies of human FGF receptor 4. Protein Expr Purif (2001) 0.79
Expression of syndecan in transformed mouse keratinocytes. Lab Invest (1992) 0.79
Cell surface glycoconjugates of gingival fibroblasts exposed to dental plaque extract. J Periodontal Res (1984) 0.78
Localization of gene for human syndecan, an integral membrane proteoglycan and a matrix receptor, to chromosome 2. Somat Cell Mol Genet (1990) 0.78
Translational suppression of syndecan-1 expression in Ha-ras transformed mouse mammary epithelial cells. Mol Biol Cell (1993) 0.78
Isoelectric focusing of macrophage culture media and the effect of the fractions on the synthesis of DNA and collagen by fibroblasts. Acta Pathol Microbiol Scand C (1979) 0.78
Proximal promoter of the murine syndecan-1 gene is not sufficient for the developmental pattern of syndecan expression in B lineage cells. Am J Hematol (2001) 0.78
Immune capacity of the chicken bursectomized at 60 hr of incubation: surface immunoglobulin and B-L (La-like) antigen-bearing cells. J Immunol (1983) 0.78
Immune capacity of the chicken bursectomized at 60 hours of incubation: failure to produce immune, natural, and autoantibodies in spite of immunoglobulin production. Cell Immunol (1983) 0.78
A rapid assay to measure collagen synthesis in cell cultures. J Biochem Biophys Methods (1980) 0.76
The effect of human dental plaque on bone resorption and hyaluronic acid synthesis in in-vitro cultures of fetal rat calvaria. Arch Oral Biol (1982) 0.76
Transcriptional targeting of adenoviral gene delivery into migrating wound keratinocytes using FiRE, a growth factor-inducible regulatory element. Gene Ther (2000) 0.76
Accumulation of heavy metals in the mole in Finland. Environ Pollut (1993) 0.75
Immunohistochemical expression of syndecan-1 in human endometrial cancer cells. Int J Mol Med (1998) 0.75
Effects of five anti-inflammatory steroids on DNA synthesis by normal skin fibroblasts in vitro. Arch Dermatol Res (1980) 0.75
Luteinizing hormone receptors in human ovarian follicles and corpora lutea during menstrual cycle and pregnancy. J Clin Endocrinol Metab (1981) 0.75
The testes of moles (Talpa europaea) retain a considerable microsomal capacity for androgen synthesis during seasonal regression. Gen Comp Endocrinol (1989) 0.75
Proximal promoter-independent activation of the far-upstream FGF-inducible response element of syndecan-1 gene. Biochem Biophys Res Commun (2000) 0.75
Effect of Mycoplasma pulmonis infection on protein and glycosaminoglycan synthesis of cultured connective tissue cells. Exp Cell Res (1983) 0.75
Lymphocyte migration molecules. Adv Exp Med Biol (1988) 0.75
Intercellular adhesion and induction of epithelialization in the metanephric mesenchyme. Cell Differ Dev (1988) 0.75
Syndecan and tenascin: induction during early tooth morphogenesis and possible interactions. Cell Differ Dev (1990) 0.75
The mapping and visual ordering of the human syndecan-1 and N-myc genes near the telomeric region of chromosome 2p. Hum Genet (1997) 0.75